ABVC BioPharma, Inc. Debt Instrument, Face Amount
ABVC BioPharma, Inc. (ABVC) had Debt Instrument, Face Amount of $346.56 thousand as of 2023-12-31, per its 10-Q filed 2024-05-17.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-04-30
- 2023-12-31: Debt Instrument, Face Amount $346.56K.
- 2023-11-17: Debt Instrument, Face Amount $1.20M.
- 2023-02-23: Debt Instrument, Face Amount $3.70M.
- 2022-07-14: Debt Instrument, Face Amount $650.00K.
USD
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2023-12-31 | $346.56K 10-Q · filed 2024-05-17 |
| 2023-11-17 | $1.20M 10-K · filed 2024-03-13 |
| 2023-02-23 | $3.70M 10-K · filed 2024-03-13 |
| 2022-07-14 | $650.00K 10-K · filed 2023-03-31 |
| 2022-03-31 | $650.00K 10-Q · filed 2022-05-16 |
| 2021-12-01 | $250.00K 10-Q · filed 2025-04-30 |
| 2021-09-30 | $650.00K 10-K · filed 2022-03-31 |
| 2021-09-07 | $67.87K 10-Q · filed 2025-04-30 |
| 2021-02-07 | $104.17K 10-Q · filed 2021-11-15 |
| 2021-01-29 | $132.33K 10-Q · filed 2021-05-10 |
| 2020-07-01 | $361.49K 10-Q · filed 2025-04-30 |
| 2020-04-14 | $124.40K 10-K · filed 2021-03-16 |
| 2019-01-21 | $1.00M 10-K · filed 2023-03-31 |
TWD
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-07-14 | 20.00M TWD 10-K · filed 2023-03-31 |